Filter:
Saturday, Track 2: “Current and Future Therapies in Liver Disease” presented by Dr. Jeffrey Teckman at the 2023 Alpha-1 National […]
Read More… from Current & Future Therapies in Liver Disease – A1NC23
Saturday, Track 1: “MZ Presentation” presented by Dr. Joseph Kasserman at the 2023 Alpha-1 National Conference. Joseph Kasserman, MD Alpha-1 […]
Saturday, Track 1: “Integrative Therapies” presented by Dr. Michael Campos at the 2023 Alpha-1 National Conference. Michael Campos, MD Alpha-1 […]
Friday, Track 2: “Overview of the Alpha-1 Biomarkers Consortium (A1BC) Study” presented by Dr. Jeanine D’Armiento, Dr. Monica Goldklang, Dr. […]
Read More… from Overview of the Alpha-1 Biomarkers Consortium (A1BC) Study – A1NC23
Friday, Track 2: “The Alpha-1 Foundation’s Research Agenda” presented by Dr. Andrew Wilson at the 2023 Alpha-1 National Conference. Andrew […]
Read More… from The Alpha-1 Foundation’s Research Agenda – A1NC23
Friday, Track 1: “Clinical Trials Explained & How A Therapy Comes to Market” presented by Dr. Mark Brantly at the […]
Read More… from Clinical Trials Explained & How A Therapy Comes to Market – A1NC23
Friday, Track 1: “Alpha-1 Antitrypsin Deficiency 101 Liver” presented by Dr. Virginia Clark at the 2023 Alpha-1 National Conference. Virginia […]
Read More… from Alpha-1 Antitrypsin Deficiency 101 Liver – A1NC23
Friday, Track 1: “Alpha-1 Antitrypsin Deficiency 101 Lung” presented by Dr. Charlie Strange at the 2023 Alpha-1 National Conference. Charlie […]
Read More… from Alpha-1 Antitrypsin Deficiency 101 Lung – A1NC23
The Alpha-1 Biomarkers Consortium (A1BC) Study presented by Spring Maleckar at the 2023 Chicago Alpha-1 Education Day. Spring Maleckar Chicago […]
Read More… from The Alpha-1 Biomarkers Consortium (A1BC) Study
Alpha-1 Liver Disease presented by Virginia Clark, MD, MS at the 2023 Orlando Alpha-1 Education Day. Virginia Clark, MD, MS […]
The Alpha-1 Coded Testing (ACT) Program & Genetic Counseling Services presented by Jesse West, RN and Michelle Owens, RN at […]
Read More… from The Alpha-1 Coded Testing (ACT) Program & Genetic Counseling Services
Alpha-1 Lung Disease and Genotypes presented by Dr. Mark Brantly at the 2023 Orlando Alpha-1 Education Day. Mark Brantly, MD […]
Scott Santarella, President & CEO, Alpha-1 Foundation & Jon Hagstrom, Chair of the Board of Directors, Alpha-1 Foundation […]
State of Alpha-1 Research presented by Dr. Andrew Wilson at the 2023 Virtual Alpha-1 Education Day. Andrew Wilson, MD, Scientific […]
Scott Santarella, President & CEO, Alpha-1 Foundation Bethesda Alpha-1 Education Day November 13, 2022 […]
Bethesda Alpha-1 Education Day November 13, 2022 Mark Brantly, MD – Jeaninr D’Armiento, MD, PhD – Robert A. Sandhaus, MD,PhD,FCCP […]
Jon Hagstrom, Chair of the Board of the Alpha-1 Foundation, welcomed the attendees of the Los Angeles Alpha-1 Education Day […]
Igor Barjaktarevic, MD, PhD provided an update on Alpha-1 research and clinical trial participation during the Los Angeles Alpha-1 Education […]
Read More… from Research Update and Clinical Trial Participation.mp4
2022 Hybrid Alpha-1 National Conference Wednesday, June 8, 2022 Moderated by: Richard Lovrich Speaker: Stephen Rennard, MD, Robert A. Sandhaus, […]
2022 Hybrid Alpha-1 National Conference Thursday, June 9, 2022 Speaker: Mark Brantly, MD, Robert A. Sandhaus, MD, PhD, FCCP, Mike […]
2022 Hybrid Alpha-1 National Conference Friday, June 10, 2022 Speaker: Mark Brantly, MD […]
Dr. Jeanine D’Armiento, Chair of the Board of Directors for the Alpha-1 Foundation, gave a an update on COVID-19 during […]
Dr. Jeanine D’Armiento, Chair of the Board of Directors for the Alpha-1 Foundation, and Dr. Mark Brantly, Scientific Director of […]
Read More… from Alpha-1 Research Registry and Clinical Trials Physician Panel
Dr. Robert A. Sandhaus, Clinical Director at the Alpha-1 Foundation, gave an update on COVID-19, and was followed by a […]
